EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIR-HLA interactions extend human CD8+ T cell lifespan in vivo

Yan Zhang, Ada Wc Yan, Lies Boelen, Linda Hadcocks, Arafa Salam, Daniel Padrosa Gispert, Loiza Spanos, Laura Mora Bitria, Neda Nemat-Gorgani, James A Traherne, Chrissy Roberts, Danai Koftori und 7 weitere

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci169496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Yan Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infection and Immunity, St George's, University of London, London, United Kingdom. Hauptthemen laut MEDLINE: Longevity, Killer Cells, Natural. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Medical Research Council, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LongevityKiller Cells, NaturalUnited StatesMiceAnimalsHumansLigandsReceptors, KIRCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

Adaptive immunityGenetic variationImmunologyT cells

Substanzen

LigandsReceptors, KIR

Autor:innen und Institutionen

  • Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
  • Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • School of Life and Health Sciences, University of Roehampton, London, United Kingdom.
  • Department of Structural Biology and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Förderung

  • Department of Health
  • Medical Research Council
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • Wellcome Trust
  • European Research Council under the European Union’s Horizon 2020 research and innovation program
  • European Union H2020 programme
  • European Union Seventh Framework Programme

Zitieren

APA

Zhang, Y., Yan, A. W., Boelen, L., Hadcocks, L., Salam, A., Gispert, D. P., Spanos, L., Bitria, L. M., Nemat-Gorgani, N., Traherne, J. A., Roberts, C., Koftori, D., Taylor, G. P., Forton, D., Norman, P. J., Marsh, S. G., Busch, R., Macallan, D. C., & Asquith, B. (2023). KIR-HLA interactions extend human CD8+ T cell lifespan in vivo. Journal of Clinical Investigation. https://doi.org/10.1172/jci169496

Vancouver

Zhang Y, Yan AW, Boelen L, Hadcocks L, Salam A, Gispert DP, et al. KIR-HLA interactions extend human CD8+ T cell lifespan in vivo. Journal of Clinical Investigation. 2023. doi:10.1172/jci169496

BibTeX
@article{Zhang2023,
  author = {Zhang, Yan and Yan, Ada Wc and Boelen, Lies and Hadcocks, Linda and Salam, Arafa and Gispert, Daniel Padrosa and Spanos, Loiza and Bitria, Laura Mora and Nemat-Gorgani, Neda and Traherne, James A and Roberts, Chrissy and Koftori, Danai and Taylor, Graham P and Forton, Daniel and Norman, Paul J and Marsh, Steven Ge and Busch, Robert and Macallan, Derek C and Asquith, Becca},
  title = {KIR-HLA interactions extend human CD8+ T cell lifespan in vivo},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci169496}
}
Kostenlos starten →